Refreshing results…
Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer
Download from aacrjournals.orgSTAT3 activation as a predictive biomarker for ruxolitinib response in head and neck cancer
UploadA protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity
UploadMissing publications? Search for publications with a matching author name.